Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Long-Term Deferred Tax (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Long-Term Deferred Tax for 16 consecutive years, with $759000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 46.74% to $759000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $759000.0, a 46.74% decrease, with the full-year FY2025 number at $759000.0, down 46.74% from a year prior.
  • Long-Term Deferred Tax was $759000.0 for Q4 2025 at Lemaitre Vascular, down from $854000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $2.8 million in Q3 2022 to a low of $759000.0 in Q4 2025.
  • A 5-year average of $1.6 million and a median of $1.6 million in 2021 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: surged 71.42% in 2022, then plummeted 54.05% in 2024.
  • Lemaitre Vascular's Long-Term Deferred Tax stood at $1.6 million in 2021, then rose by 11.43% to $1.7 million in 2022, then tumbled by 42.52% to $1.0 million in 2023, then surged by 42.07% to $1.4 million in 2024, then crashed by 46.74% to $759000.0 in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Long-Term Deferred Tax are $759000.0 (Q4 2025), $854000.0 (Q3 2025), and $1.5 million (Q2 2025).